C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/00 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2552750
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.
L'invention concerne des anticorps spécifiques du M-CSF, dérivés de RX-1 ou à base de RX1, ainsi que des compositions pharmaceutiques contenant un tel anticorps, des kits contenant une composition pharmaceutique, et des méthodes pour prévenir et traiter la perte osseuse chez un sujet souffrant d'une affection ostéolytique.
Calderon-Cacia Maria
Harrowe Gregory Martin
Horwitz Arnold H.
Kavanaugh William Michael
Koths Kirston
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
Xoma Technology Ltd.
LandOfFree
M-csf-specific monoclonal antibody and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with M-csf-specific monoclonal antibody and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M-csf-specific monoclonal antibody and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1852931